Vote Scores

Home / Companies / Alto Neuroscience, Inc. / 12 May 2026

Meeting · year to 30 June 202628 filers reporting

Alto Neuroscience, Inc.: meeting of 12 May 2026

Votes reported on Form N-PX, item by item

28 Form N-PX filers reported votes at the Alto Neuroscience, Inc. meeting of 12 May 2026. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 61.3% of reported votes for; 19 filers withheld from or voted against at least one nominee.

78 vote records from 24 filers. 0 of the 24 filers that marked the item either way voted against management.

25.0% for0.0% against75.0% other0.0% against management24 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

26 vote records from 2 filers. 0 of the 1 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

50.0% for0.0% against50.0% other0.0% against management2 filers77.5% for0.0% against22.5% other0.0% against management939,252 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

39 vote records from 24 filers. 0 of the 24 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management24 filers100.0% for0.0% against0.0% against management2,143,066 reported shares
4

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

5 vote records from 4 filers. 4 of the 4 filers that marked the item either way voted against management.

0.0% for100.0% against100.0% against management4 filers0.0% for100.0% against100.0% against management11,172 reported shares, counted once per item in this group
5

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

77 vote records from 26 filers. 23 of the 26 filers that marked the item either way voted against management.

3.8% for88.5% against7.7% other88.5% against management26 filers22.0% for78.0% against78.0% against management4,314,183 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors3. Auditor
VanguardForFor
BlackRock and iSharesSplit or no voteFor
FidelitySplit or no voteFor
DimensionalSplit or no voteFor
American CenturySplit or no voteFor
Franklin TempletonSplit or no voteFor
EquitableSplit or no voteFor
Charles SchwabForFor
John Hancock and ManulifeSplit or no voteFor
Goldman SachsForFor
Jackson National fundsSplit or no voteFor
Northern Trust and FlexSharesSplit or no voteFor
T. Rowe PriceSplit or no voteFor
Victory CapitalSplit or no voteFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Alto Neuroscience, Inc. meeting?

28 Form N-PX filers reported votes at the meeting of 12 May 2026. On say-on-pay, 0 of 1 voted against management (0.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Alto Neuroscience, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Alto Neuroscience, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Alto Neuroscience, Inc. with a meeting date within three days of 12 May 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.